AMBROSIONI, ETTORE
 Distribuzione geografica
Continente #
NA - Nord America 4.516
AS - Asia 3.929
EU - Europa 3.717
SA - Sud America 245
AF - Africa 179
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.592
Nazione #
US - Stati Uniti d'America 4.462
GB - Regno Unito 1.389
SG - Singapore 1.129
CN - Cina 1.044
VN - Vietnam 870
IT - Italia 597
DE - Germania 424
UA - Ucraina 273
FR - Francia 261
HK - Hong Kong 246
IN - India 241
SE - Svezia 212
RU - Federazione Russa 208
BR - Brasile 187
IE - Irlanda 105
ZA - Sudafrica 94
JP - Giappone 84
EE - Estonia 81
KR - Corea 74
BD - Bangladesh 55
PH - Filippine 33
FI - Finlandia 32
CA - Canada 28
NL - Olanda 28
AR - Argentina 27
SC - Seychelles 26
ID - Indonesia 25
TG - Togo 22
IQ - Iraq 20
PL - Polonia 20
MX - Messico 18
CI - Costa d'Avorio 17
TH - Thailandia 16
CH - Svizzera 15
JO - Giordania 15
TR - Turchia 15
BE - Belgio 13
GR - Grecia 11
BG - Bulgaria 10
EC - Ecuador 9
LB - Libano 9
PK - Pakistan 9
TW - Taiwan 9
UZ - Uzbekistan 8
AT - Austria 7
PE - Perù 6
RO - Romania 6
HU - Ungheria 5
SA - Arabia Saudita 5
CL - Cile 4
MY - Malesia 4
AU - Australia 3
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
CO - Colombia 3
ES - Italia 3
MA - Marocco 3
NG - Nigeria 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
CV - Capo Verde 2
EG - Egitto 2
GH - Ghana 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
KH - Cambogia 2
LV - Lettonia 2
ME - Montenegro 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
AO - Angola 1
BB - Barbados 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
HN - Honduras 1
IR - Iran 1
LT - Lituania 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SY - Repubblica araba siriana 1
UG - Uganda 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.592
Città #
Southend 1.293
Singapore 743
Santa Clara 391
Ashburn 336
San Jose 304
Fairfield 296
Hong Kong 233
Wilmington 213
Chandler 197
Princeton 193
Hefei 176
Jacksonville 170
Ho Chi Minh City 168
Dong Ket 144
Woodbridge 136
Hanoi 135
Seattle 135
Houston 117
Beijing 113
Cambridge 111
Boardman 108
Dublin 105
Lauterbourg 103
Ann Arbor 98
Westminster 95
Padova 91
Nanjing 89
Turin 85
Berlin 79
Tokyo 79
Council Bluffs 75
Los Angeles 75
Seoul 69
New York 68
Dallas 64
Milan 54
Buffalo 53
Medford 51
Saint Petersburg 41
Shenyang 40
Jinan 37
Helsinki 30
Nanchang 29
Phoenix 27
Hebei 24
Jiaxing 24
Mahé 24
São Paulo 24
Changsha 23
Da Nang 23
Guangzhou 23
Mülheim 23
San Diego 23
Lomé 22
Norwalk 22
Verona 22
Dearborn 21
Haiphong 21
Tianjin 21
Rome 20
Orem 19
Shanghai 19
Zhengzhou 19
Bologna 18
Abidjan 17
Denver 17
Olalla 17
Redondo Beach 17
Atlanta 16
Warsaw 16
Amman 15
Bengaluru 14
Frankfurt am Main 14
San Francisco 14
Bremen 13
Brooklyn 12
Ningbo 12
Montreal 11
Munich 11
Shenzhen 11
Brussels 10
Hải Dương 10
Manila 10
Baghdad 9
Biên Hòa 9
Sofia 9
Zelarino 9
Amsterdam 8
Bangkok 8
Bern 8
Chennai 8
Chicago 8
Haikou 8
Kunming 8
Paris 8
Phủ Lý 8
Quận Bình Thạnh 8
Taiyuan 8
The Dalles 8
Xi'an 8
Totale 8.081
Nome #
Effects of treatment with zofenopril in men and women with acute myocardial infarction: gender analysis of the SMILE Program. 512
Tolerability of nebivolol in head-to head clinical trials vs. other cardioselective beta-blockers in the treatment of hypertension. A meta-analysis. 509
Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4. 217
Confronto tra BNP e NT-proBNP nella valutazione dei pazienti con insufficienza cardiaca di origine ipertensiva e non ipertensiva 200
Zofenopril and ramipril in patients with left ventricular systolic dysfunction after acute myocardial infarction: A propensity analysis of the Survival of Myocardial Infarction Long-term Evaluation (SMILE) 4 study 200
BNP e parametri ecocardiografici in pazienti con insufficienza cardiaca. 188
Assessment of b-type natriuretic peptide (BNP) and N-terminal (NT)-proBNP in hypertensive patients with heart failure 185
Confronto tra BNP e NT-proBNP nel monitoraggio dei pazienti ipertesi con insufficienza cardiaca 159
BNP e NT-proBNP nella valutazione dei pazienti con insufficienza cardiaca di origine ipertensiva e non ipertensiva. 158
Efficacy of zofenopril in combination with thiazide diuretics in patients with acute myocardial infarction: A pooled individual data analysis of four randomized, double-blind, controlled, prospective studies 155
Cardiomiopatia peripartum: stato di avanzamento della proposta di un registro italiano. 151
Manometric brachial arteriography, a new technique for non invasive high-precision blood pressure measurement:development and validation through comparison with intra-arterial blood pressure 151
Temporal trend of antihypertensive drugs therapy and blood pressure control in the Brisighella Heart Study. 147
Efffects of telmisartan and bisoprolol on blood pressure, peripheral haemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients. 147
Revisione critica del ruolo della digitale nel trattamento del paziente con scompenso cardiaco. 146
Zofenopril 15 anni con il cuore nel cuore. 144
Valutazione di peptide natriuretico atriale di tipo B (BNP) e di frammento N-terminale di pro-BNP in pazienti con insufficienza cardiaca di varia eziologia. 140
Approccio integrato alle linee guida sul trattamento del paziente a rischio cardiovascolare 140
Il significato clinico degli acufeni nei pazienti con scompenso cardiaco. 136
Il significato clinico degli acufeni nei pazienti con scompenso cardiaco 135
Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients 133
An integrated approch to care on heart failure patients with hypertension: effects on NYHA class and hospitalization. 131
Effects of early Ace-inhibition in patients with acute myocardial infarction and metabolic syndrome. 129
La percezione clinica del rischio cardiovascolare. Il questionario. 128
Il ruolo dei FANS nell'instabilizzazione del quadro clinico dei pazienti con insufficienza cardiaca. 128
New pharmacological treatments of acutely decompensated heart failure. Critical review of new drugs options. 128
Serum cholestrol levels on admission and survival in patients with acute myocardial infarction treated with zofenopril: a post hoc analysis of the Survival of Myocardial Infarction Long-Term Evaluation trial. 128
Lo scompenso cardiaco. 127
Cost effctiveness of zofenopril in patients with left ventricular systolic dysfunction afetr acute myocardial infarction: a post-hoc analysys of the smile-4 study. 127
BNP e parametri ecocardiografici in pazienti ipertesi con insufficienza cardiaca. 126
Early Treatment With Zofenopril And Ramipril In Combination With Acetyl Salicylic Acid In Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results Of A 5-Year Follow-Up Of Patients Of The Smile-4 Study 124
Effects of early ACE-inhibition in patients with no-STEMI acute myocardial infarction. 123
Pharmacoeconomic approch to the treatment of hypertension: from clinical trials to clinical practice. 122
Aspetti ecocardiografici e sviluppo di disordini ipertensivi correlati alla gravidanza in donne gravide con alterazioni della flussimetria utero-placentare 121
Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study 121
Compliance of antihypertensive treatment and monotherapy. Behaviour of the calcium-channel blocker lercanidipine 120
Choelsterol levels, plasma renin activity and incidence of stable hypertension in young subjects with high-normal blood pressure. 119
Sondaggio sulla percezione clinica del rischio cardiovascolare nella pratica clinica. Risultati del sondaggio. 117
Ipertensione arteriosa e fattori di rischio in Italia: analisi dei rislutati dei principali studi osservazioni nazionali. 116
Zofenopril is a cost-effective treatment for patients with left ventricular systolic dysfunction following acute myocardial infarction: a pharmacoeconomic analysis of the SMILE-4 study 114
Sondaggio sulla percezione del rischio cariovascolare. Documento di consenso. 113
2012 consensus document of the Italian Society of Hypertension (SIIA): strategies to improve blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. 112
Ipertensione e fattori di rischio in Italia: analisi dei risultati dei principali studi osservazionali. 111
Dalla multidisciplinarità alla complessità clinica: come affrontare efficacemente la storia naturale della medicina 111
Effects of non steroidal anti-inflammatory drugs on clinical aspects and blood pressure in patients with heart failure. 111
Measuremnt and judgement of home blood pressure. 110
Left ventricular systolic and diastolic function and geometric patterns in elderly hypertensives. 109
Erratum: National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities [High Blood Press Cardiovasc Prev, (2014), 21, (29-36), DOI 10.1007/s40292-013-0034-z] 108
Compliance to antihypertensive treatment and monotherapy. Behavoiur of the calcium-channel blocker lercanidipine. 107
Efficacy of Zofenopril Compared with Placebo and Other Angiotensin-converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction and Previous Cardiovascular Risk Factors: A Pooled Individual Data Analysis of 4 Randomized, Double-blind, Controlled, Prospective Studies 106
null 105
Scienza, coscienza e portafoglio. 105
Consapevolezza, trattamento e controllo della pressione artersiosa e modificazioni temporali nell'impiego dei farmaci antiipertensivi. 104
Efficacy and Safety of Zofenopril Versus Ramipril in the Treatment of Myocardial Infarction and Heart Failure: A Review of the Published and Unpublished Data of the Randomized Double-Blind SMILE-4 Study 104
Serum cholesterol levels, blood pressure response to stress and incidence of stable hypertension in young subjects with high normal blood pressure. 104
La doxazosina compensa gli effetti indesiderati del beta-blocco. 103
COST EFFECTIVENESS OF ZOFENOPRIL IN THE TREATMENT OF PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION AFTER ACUTE MYOCARDIAL INFARCTION: A POST-HOC ANALYSIS OF THE SMILE-4 STUDY 99
Riduzione dell'incidenza di ospedalizazzione in una popolazione di pazienti affetti da insufficienza cardiaca seguiti attraverso un modello di gestione ambulatoriale integrata. 99
Cardioprotective role of zofenopril in hypertensive patients with acute myocardial infarction: a pooled individual data analysis of the SMILE studies 99
Correlazione tra risposta al test cardiopolmonare a carico costante con la classe NYHA e con la frazione di eiezione ecocardiografica nei pazienti con insufficienza cardiaca. 98
Effect of an integrated approch to care in heart failure patients with compromised or preserved left ventricular function. 98
Efficacy of zofenopril in combination with amlodipine in patients with acute myocardial infarction: a pooled individual patient data analysis of four randomized, double-blind, controlled, prospective studies. 98
Denervazione delle arterie renali nel trattamento dell'ipertensione arteriosa resistente: definizione della patologia, selezione dei pazienti e descrizione della procedura. 97
Il rischio cardiovascolare totale. 96
Pharmacoeconomic and cost-benefit aspects. 93
Tra scienza, coscienza e portafoglio: a chi l'ultima parola? 92
null 92
Prevalence of tinnitus in a population of hypertensive patients referring to a hypertensive clinic. 90
Zofenopril and ramipril plus ASA in post-myocardial infarction patients with left ventricular systolic dysfunction: a post-hoc analysis in preserved or impaired left ventricular fraction at entry 89
Left ventricualr structure and function and development of pregnancy-related hypertensive disorders in pregnant women with alterated utero-plancetal flow. 89
Confronto tra un AIIRA ed un Beta-bloccante sul controlo delal pressione arteriosa, emodinamica periferica e profilo lipidico in pazienti ipertesi dislipidemici trattati con una statina. 89
null 87
Temporal trend of antihypertensive drugs therapy and blood pressure control in the Brisighella Herat Study. 86
Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: A meta-analysis of individual data of four randomized, double-blind, prospective studies 86
Cardioprotective role of zofenopril in patients with acute myocardial infarction: a pooled individual data analysis of four randomised, double-blind, controlled, prospective studies 85
Effect of early ACE-inihibition in patients with acute myocardila infarction and metabolic syndrome. 85
Influenza del diabete sui parametri clinici e strumentali di insufficienza cardiaca in una popolazione di pazienti ipertesi. 83
Strategies for improving blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. 2012 Position paper of the Italian Society of Hypertension. 81
Assessment of b-type natriuretic peptide (BNP) and N-terminal (NT)-proBNP in patients with heart failure of hypertensive or not hypertensive origin 81
Monoterapia e compliance al trattamento antiipertensivo. Comportamento di un Ca-antagonista, lercanidipina 79
Factors influencing the effect of statins on blood pressure in hypertensive patients. 79
Blood pressure control in Italy: results of recent surveys on hypertension. 79
Effects of AT1 receptor and beta1 receptor bloking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients. 79
Denervation of the renal arteries in the treatment of resistant hypertension: Definition of the disease, patient selection and description of the procedure. Reference document 2012 of the Italian Society of Hypertension (SIIA). [Denervazione delle arterie renali nel trattamento dell'ipertensione arteriosa resistente: Definizione della patologia, selezione dei pazienti e descrizione della procedura. Documento di indirizzo 2012 della Società Italiana dell'Ipertensione Arteriosa (SIIA)] 78
Left ventricular structure and function and development of pregnancy-related hypertensive disorders in pregnant women with alterated utero-plancetal flow. 78
Left ventricular strutcture and function and development of pregnancy-related hypertensive disorders in pregnant women with alterated utero-placental flow. 77
null 76
Effetti della gestione ambulatoriale con approccio specialsitico dedicato del paziente iperteso con insufficienza cardiaca. 76
null 74
null 74
null 73
null 71
Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosied hypertensive patients. 70
Blood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension. 69
Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: resuls of a randomized, double-blind, parallel-group, multiceter, european Study (SMILE-4). 69
null 68
Prevalence of tinnitus in a population of hypertensive patients reffering to a hypertensive clinic. 67
null 66
Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure. 66
null 65
Totale 11.750
Categoria #
all - tutte 32.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.964


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021358 0 0 0 0 0 0 0 0 0 0 0 358
2021/20221.378 121 71 86 73 158 91 15 99 62 62 306 234
2022/20231.294 147 185 73 146 67 78 41 88 221 55 152 41
2023/2024346 16 60 28 25 24 65 22 36 13 23 16 18
2024/20251.605 64 286 126 94 475 70 93 11 27 15 38 306
2025/20264.029 204 401 427 267 402 275 338 285 638 287 177 328
Totale 12.819